Authors:
ZHOU XP
HOANG JM
LI YJ
SERUCA R
CARNEIRO F
SOBRINHOSIMOES M
LOTHE RA
GLEESON CM
RUSSELL SEH
MUZEAU F
FLEJOU JF
HOANGXUAN K
LIDEREAU R
THOMAS G
HAMELIN R
Citation: Xp. Zhou et al., DETERMINATION OF THE REPLICATION ERROR PHENOTYPE IN HUMAN TUMORS WITHOUT THE REQUIREMENT FOR MATCHING NORMAL DNA BY ANALYSIS OF MONONUCLEOTIDE REPEAT MICROSATELLITES, Genes, chromosomes & cancer, 21(2), 1998, pp. 101-107
Authors:
TERRIS B
MUZEAU F
SAUVANET A
BELGHITI J
FLEJOU JF
Citation: B. Terris et al., P53 GENE-MUTATIONS AND ABNORMAL EXPRESSION OF P53 PROTEIN IN TUMORS OF THE AMPULLA OF VATER, Gastroenterologie clinique et biologique, 22(5), 1998, pp. 495-499
Authors:
OLSCHWANG S
HAMELIN R
LAURENTPUIG P
THUILLE B
DERYCKE Y
LI YJ
MUZEAU F
GIRODET J
SALMON RJ
THOMAS G
Citation: S. Olschwang et al., ALTERNATIVE GENETIC PATHWAYS IN COLORECTAL CARCINOGENESIS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(22), 1997, pp. 12122-12127
Citation: F. Muzeau et al., LOSS OF HETEROZYGOSITY ON CHROMOSOME-9 AND P16 (MTS1, CDKN2) GENE-MUTATIONS IN ESOPHAGEAL CANCERS, International journal of cancer, 72(1), 1997, pp. 27-30
Authors:
COTTU PH
MUZEAU F
ESTREICHER A
FLEJOU JF
IGGO R
THOMAS G
HAMELIN R
Citation: Ph. Cottu et al., INVERSE CORRELATION BETWEEN RER(-CANCER CELL-LINES() STATUS AND P53 MUTATION IN COLORECTAL), Oncogene, 13(12), 1996, pp. 2727-2730
Authors:
MUZEAU F
FLEJOU JF
POTET F
BELGHITI J
THOMAS G
HAMELIN R
Citation: F. Muzeau et al., PROFILE OF P53 GENE MUTATION AND ABNORMAL EXPRESSION OF P53 PROTEIN IN THE 2 TYPES OF ESOPHAGEAL CANCER, Gastroenterologie clinique et biologique, 20(5), 1996, pp. 430-437
Citation: F. Muzeau et al., FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-9 AND LOW INCIDENCE OF P16 (MTS1) GENE MUTATION IN ESOPHAGEAL CANCER, Gastroenterology, 110(4), 1996, pp. 565-565
Authors:
LAGORCE C
FLEJOU JF
MUZEAU F
HENIN D
POTET F
Citation: C. Lagorce et al., ABSENCE OF C-KI-RAS GENE MUTATION IN MALIGNANT AND PREMALIGNANT BARRETTS-ESOPHAGUS, JCP. Clinical molecular pathology, 48(4), 1995, pp. 198-199
Citation: Jf. Fleiou et al., SPINDLE-CELL CARCINOMA OF THE ESOPHAGUS - THE STUDY OF THE P53 TUMOR-SUPPRESSOR GENE-PRODUCT SUGGESTS A CLONAL ORIGIN, Gastroenterology, 108(4), 1995, pp. 468-468
Authors:
MUZEAU F
FLEJOU JF
LAGORCE C
HAMELIN R
HENIN D
POTET F
Citation: F. Muzeau et al., CARCINOGENESIS OF BARRETTS-ESOPHAGUS - FREQUENT IMPLICATION OF THE P53 TUMOR-SUPPRESSOR GENE, NO IMPLICATION OF THE K-RAS ONCOGENE, Gastroenterology, 108(4), 1995, pp. 512-512
Authors:
FLEJOU JF
MUZEAU F
POTET F
LEPELLETIER F
FEKETE F
HENIN D
Citation: Jf. Flejou et al., OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE-PRODUCT IN ESOPHAGEALAND GASTRIC CARCINOMAS, Pathology research and practice, 190(12), 1994, pp. 1141-1148
Authors:
FLEJOU JF
PARAF F
POTET F
MUZEAU F
FEKETE F
HENIN D
Citation: Jf. Flejou et al., P53 PROTEIN EXPRESSION IN BARRETTS ADENOCARCINOMA - A FREQUENT EVENT WITH NO PROGNOSTIC-SIGNIFICANCE, Histopathology, 24(5), 1994, pp. 487-489
Authors:
FLEJOU JF
PARAF F
MUZEAU F
FEKETE F
HENIN D
JOTHY S
POTET F
Citation: Jf. Flejou et al., EXPRESSION OF C-ERBB-2 ONCOGENE PRODUCT IN BARRETTS ADENOCARCINOMA - PATHOLOGICAL AND PROGNOSTIC CORRELATIONS, Journal of Clinical Pathology, 47(1), 1994, pp. 23-26
Authors:
HAMELIN R
FLEJOU JF
MUZEAU F
POTET F
LAURENTPUIG P
FEKETE F
THOMAS G
Citation: R. Hamelin et al., TP53 GENE-MUTATIONS AND P53 PROTEIN IMMUNOREACTIVITY IN MALIGNANT ANDPREMALIGNANT BARRETTS-ESOPHAGUS, Gastroenterology, 107(4), 1994, pp. 1012-1018
Authors:
FLEJOU JF
MUZEAU F
HAMELIN R
LAURENTPUIG P
POTET F
THOMAS G
Citation: Jf. Flejou et al., TP53 GENE-MUTATIONS AND P53 PROTEIN IMMUNOREACTIVITY IN MALIGNANT ANDPREMALIGNANT BARRETTS-ESOPHAGUS, Gastroenterology, 106(4), 1994, pp. 10000386-10000386
Authors:
FLEJOU JF
PARAF F
MUZEAU F
HENIN D
FEKETE F
JOTHY S
POTET F
Citation: Jf. Flejou et al., C-ERBB-2 ONCOGENE PRODUCT EXPRESSION AND PROGNOSIS IN BARRETTS ADENOCARCINOMA, Gastroenterology, 104(4), 1993, pp. 400-400